Nutex Health
(NASDAQ) NUTX
Nutex Health Financials at a Glance
Market Cap
$755.30M
Revenue (TTM)
$875.26M
Net Income (TTM)
$64.21M
EPS (TTM)
$9.72
P/E Ratio
11.15
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$109.68
Volume
7,274
Open
$108.86
Price
$109.68
Volume
7,274
Open
$108.86
Previous Close
$109.68
Daily Range
$108.31 - $113.38
52-Week Range
$77.21 - $193.07
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$109.68
Volume
7,274
Open
$108.86
Previous Close
$109.68
Daily Range
$108.31 - $113.38
52-Week Range
$77.21 - $193.07
NUTX News
NUTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nutex Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
944
CEO
Thomas T. Vo, MD, MBA
Website
www.nutexhealth.comHeadquarters
Houston, TX 77081, US
NUTX Financials
Key Financial Metrics (TTM)
Gross Margin
51%
Operating Margin
31%
Net Income Margin
7%
Return on Equity
31%
Return on Capital
35%
Return on Assets
7%
Earnings Yield
8.97%
Dividend Yield
0.00%
Payout Ratio
77.15%
Stock Overview
Market Cap
$755.30M
Shares Outstanding
6.97M
Volume
7.27K
Short Interest
0.00%
Avg. Volume
206.08K
Financials (TTM)
Gross Profit
$444.28M
Operating Income
$275.63M
EBITDA
$296.15M
Operating Cash Flow
$248.13M
Capital Expenditure
$2.53M
Free Cash Flow
$245.60M
Cash & ST Invst.
$185.57M
Total Debt
$351.39M
Nutex Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$151.68M
-41.1%
Gross Profit
$46.14M
-67.4%
Gross Margin
30.42%
N/A
Market Cap
$755.30M
N/A
Market Cap/Employee
$944.12K
N/A
Employees
800
N/A
Net Income
$11.83M
-80.8%
EBITDA
$36.10M
-69.6%
Quarterly Fundamentals
Net Cash
$165.82M
+44.1%
Accounts Receivable
$319.44M
+35.3%
Inventory
$2.87M
+0.6%
Long Term Debt
$328.09M
+5.0%
Short Term Debt
$23.30M
-16.0%
Return on Assets
6.99%
N/A
Return on Invested Capital
35.13%
N/A
Free Cash Flow
$68.98M
+20282.3%
Operating Cash Flow
$70.39M
+131561.7%